{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:35:05Z","timestamp":1787834105598,"version":"build-2784847793"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T00:00:00Z","timestamp":1352246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048780","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T23:28:40Z","timestamp":1352330920000},"page":"e48780","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi"],"prefix":"10.1371","volume":"7","author":[{"given":"Isabella Aparecida Salerno","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina de Siqueira","family":"Paladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Alves de Souza","family":"J\u00fadice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo L. O. R.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara L\u00facia","family":"Barbi\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1590\/S0102-311X2008001200028","article-title":"Forum: geographic spread and urbanization of visceral leishmaniasis in Brazil. Postscript: new challenges in the epidemiology of <italic>Leishmania chagasi<\/italic> infection","volume":"24","author":"ELT Nascimento","year":"2008","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"ref2","first-page":"1","article-title":"Control of leishmaniasis. Report of the Expert Committee. World Health Organization","volume":"949","year":"2010","journal-title":"Tech Rep Ser"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"H Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref6","first-page":"277","article-title":"Leishmaniasis: drug resistance and natural products (review)","volume":"22","author":"T Polonio","year":"2008","journal-title":"Int J Mol Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3201\/eid0202.960213","article-title":"The reemergence of visceral leishmaniais in Brazil","volume":"2","author":"JR Arias","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"HW Murray","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874104501105010031","article-title":"Structures, targets and recent approaches in anti-leishmanial drug discovery and development","volume":"5","author":"K Seifert","year":"2011","journal-title":"Open Med Chem J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.phymed.2011.03.004","article-title":"Plant derived therapeutics for the treatment of Leishmaniasis","volume":"18","author":"R Sen","year":"2011","journal-title":"Phytomedicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0030-1250663","article-title":"Current approaches to discover marine antileishmanial natural products","volume":"77","author":"AG Tempone","year":"2011","journal-title":"Planta Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"TS Tiuman","year":"2011","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1039\/c0ob00086h","article-title":"Tellurium: an element with great biological potency and potential","volume":"8","author":"LA Ba","year":"2010","journal-title":"Org Biomol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1590\/S0001-37652009000300006","article-title":"A glimpse on biological activities of tellurium compounds","volume":"81","author":"RLOR Cunha","year":"2009","journal-title":"An Acad Bras Cienc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2011.12.003","article-title":"Immunomodulating tellurium compounds as anti-cancer agents","volume":"22","author":"B Sredni","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"ref16","first-page":"6390","article-title":"Therapeutic potential of selenium and tellurium compounds: Opportunities yet unrealised. Dalton Trans","volume":"41","author":"ER Tiekink","year":"2012"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semcancer.2006.09.004","article-title":"On the potential of thioredoxin reductase inhibitors for cancer therapy","volume":"16","author":"S Urig","year":"2006","journal-title":"Seminars Cancer Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-2952(97)00517-0","article-title":"Antioxidative properties of organotellurium compounds in cell systems","volume":"55","author":"E Wieslander","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"ref19","first-page":"755","article-title":"Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg Med Chem Lett","volume":"15","author":"RLOR Cunha","year":"2005"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.fct.2008.04.010","article-title":"Bcl-2 expression and apoptosis induction in human HL-60 leukaemic cells treated with a novel organotellurium (IV) compound RT-04","volume":"46","author":"TS Abodanza","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2008.04.001","article-title":"Protective effect of the organotelluroxetane RF-07 in pilocarpine-induced status epilepticus","volume":"31","author":"DS Persike","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"25305","DOI":"10.1074\/jbc.M203034200","article-title":"Functional analysis of cathepsin B-like cysteine proteases from <italic>Leishmania donovani<\/italic> complex. Evidence for the activation of latent transforming growth factor beta","volume":"277","author":"A Somanna","year":"2002","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-6-3","article-title":"Role of <italic>Leishmania (Leishmania) chagasi<\/italic> amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition","volume":"6","author":"V Mundodi","year":"2005","journal-title":"BMC Mol Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3347\/kjp.2009.47.3.213","article-title":"A novel organotellurium compound (RT-01) as new antileishmanial agent","volume":"47","author":"CBC Lima","year":"2009","journal-title":"Korean J Parasitol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0014-4894(90)90024-7","article-title":"Lysosomal depletion in macrophages from spleen and foot lesions of <italic>Leishmania<\/italic>-infected hamster","volume":"71","author":"CL Barbi\u00e9ri","year":"1990","journal-title":"Exp Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/om980738d","article-title":"Addition reaction of p-methoxyphenyltellurium trichloride to 3-hydroxy alkynes","volume":"18","author":"G Zeni","year":"1999","journal-title":"Organometallics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/IAI.71.3.1225-1233.2003","article-title":"<italic>Nitric oxide partially controls Coxiella burnetii<\/italic> phase II infection in mouse primary macrophages","volume":"71","author":"DS Zamboni","year":"2003","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parint.2005.01.001","article-title":"Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis","volume":"54","author":"A Dutta","year":"2005","journal-title":"Parasitol Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-4758(96)40010-2","article-title":"A simple method for quantifying <italic>Leishmania<\/italic> in tissues of infected animals","volume":"13","author":"HC Lima","year":"1997","journal-title":"Parasitol Today"},{"key":"ref30","first-page":"244","article-title":"Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem","volume":"335","author":"SS Cotrin","year":"2004"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against <italic>Leishmania<\/italic> intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"G De Muylder","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref32","first-page":"11","article-title":"Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it","volume":"2","author":"LH Freitas-Junior","year":"2012","journal-title":"Int J Parasitol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkn509","article-title":"Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of <italic>Leishmania braziliensis<\/italic> and <italic>Leishmania chagasi<\/italic> infections","volume":"63","author":"DC Miguel","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ejmech.2009.01.016","article-title":"Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines","volume":"44","author":"N Sunduru","year":"2009","journal-title":"Eur J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"JD Berman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref36","unstructured":"Campbell TW (2004) Clinical Chemistry of Mammals: Laboratory Animals and Miscellaneous Species. In: Thrall MA, Baker DC, Campbell TW, DeNicola DB, Fettman MJ, Lassen ED Rebar A, Weiser G, editors. Veterinary Hematology and Clinical Chemistry. Philadelphia: Lippcott Williams &amp; Wilkins, 463\u2013478."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1515\/BC.2009.125","article-title":"Irreversible inhibition of cathepsins B, L, S and K by hypervalent tellurium compounds","volume":"390","author":"RLOR Cunha","year":"2009","journal-title":"Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Reviews"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/ic971456t","article-title":"Tellurium compounds: Selective inhibition of cysteine proteases and model reaction with thiols","volume":"37","author":"A Albeck","year":"1998","journal-title":"Inorg Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T17:03:56Z","timestamp":1687799036000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048780"}},"subtitle":[],"editor":[{"given":"Dan","family":"Zilberstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,7]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048780","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,7]]}}}